An estimated 900,000 veterans of a population of 6.7 million VHA patients met the criteria for LCS.
Recent studies show that nivolumab was associated with increased overall survival rate when compared to docetaxel in patients with advanced squamous cell non-small cell lung cancer.
The number of incidental pulmonary nodules has increased though the number of lung cancer cases remained stable.
CMS announced it has drafted a reimbursement proposal to cover annual computed tomography (CT) scans for high-risk patients.
The government is evaluating the risks and benefits associated with low-dose CT scans and potential coverage changes for Medicaid patients.
Low-dose computed tomography screening is a low-cost strategy that can help the estimated 4.9 million Medicare patients that could meet criteria for lung cancer.
Further research into smoking cessation within screening programs may continue to decrease smoking rates.
The FDA has granted accelerated approval to Zykadia (ceritinib) in patients with metastatic ALK-positive non-small cell lung cancer who have progressed on or are intolerant to crizotinib.
Screening urged for adults aged 55 to 80 years with 30 pack-year history who smoke or recently quit